Show simple item record

dc.contributor.authorOyelowo, Olatoye
dc.description.abstractThe objectives of this study were to 1) determine the relative importance of the attributes of the Angiotensin Converting Enzyme Inhibitors (ACEIs) and to 2) measure the indirect willingness to pay (WTP) for improvements in ACEI attributes. A cross-sectional, telephone survey adapted discrete choice experiment was conducted using the Georgia Poll. The average respondent in this survey was white, female, with an average household income of between $35,000 and $49,999 per annum. The relative importance of ACEI attributes was risk of side effects, dosage schedule, efficacy and cost respectively. Respondents are WTP $179.32/ month for reduction in risk of side effects, WTP $52.02/ month for improvement in efficacy and respondents are WTP $61.78/ month for improvement in dosage convenience. In conclusion, this study establishes the relative importance of ACEI attributes and shows that patients are willing to participate in antihypertensive treatment choice.
dc.subjectPatient preferences
dc.subjectDiscrete choice experiment
dc.subjectWillingness to pay
dc.subjectGeorgia poll
dc.subjectTelephone survey
dc.subjectTreatment choice
dc.titlePatient preferences for antihypertensive therapy in a cost benefit analysis contex
dc.title.alternativethe role of the Angiotensin Converting Enzyme Inhibitors in treatment considerations for hypertension
dc.description.departmentPharmaceutical and Biomedical Sciences
dc.description.advisorRandall Tackett
dc.description.committeeRandall Tackett
dc.description.committeeChristopher Cook
dc.description.committeeJames Bason
dc.description.committeeWilliam Wade

Files in this item


There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record